Search Results 241-250 of 17453 for Mmol

  1. Academics - Find a Program at Mayo Clinic College of Medicine & Science

    Search the more than 400 medical, surgical, health sciences, and biomedical research training programs at Mayo Clinic College of ...

  2. A Study to Evaluate AMG 701 in Subjects with Multiple Myeloma - Mayo Clinic

    Serum phosphorus ≥ 2.0 mg/dL (≥ 0.6 mmol/L) within 7 days of day 1;; A subject who does not meet this inclusion criteria may be treated with phosphate ...

  3. A Study to Evaluate the Safety and Effectiveness of Felzartamab in IgA Nephropathy - Mayo Clinic

    Participation eligibility · Glycated hemoglobin (HbA1c) < 8.0% or < 64 mmoL/mol.; · No diabetic retinopathy known; · No peripheral neuropathy known.

  4. https://www.mayoclinic.org/spanish_organization_concepts.xml

  5. Safety of Regional Citrate Anticoagulation Delivered by the Multifiltratepro System in Continuous Renal Replacement Therapy - Mayo Clinic

    Participation eligibility · Metabolic alkalosis as defined by serum bicarbonate greater than 30 mmol/L and arterial pH greater than 7.55. · A female who is ...

  6. https://www.mayoclinic.org/chinese_organization_concepts.xml

  7. Study to Evaluate the Safety and Effectiveness of BMS-986036 in Adults with Nonalcoholic Steatophepatitis (NASH) and Compensated Liver Cirrhosis - Mayo Clinic

    Fasting plasma glucose < 60 mg/dL (< 3.33 mmol/L) or > 350 mg/dL (> 19.43 mmol/L);; Hemoglobin A1c ≥ 10%;; Fasting TGs > 500 mg/dL;; Estimated glomerular ...

  8. Iberdomide, Daratumumab, Bortezomib, and Dexamethasone for Treatment of Newly Diagnosed Multiple Myeloma, IDEAL Study - Mayo Clinic

    ... mmol/L) * Gastrointestinal disease that may significantly alter the absorption of iberdomide * History of anaphylaxis or hypersensitivity to thalidomide ...

  9. A Study to Evaluate AL102 to Treat Patients with Progressing Desmoid Tumors - Mayo Clinic

    0 (\>300 mg/dL or \>3.42 mmol/L). 9. ECG Exclusions (Part A only) 1. Mean QT interval corrected for heart rate using Fridericia's formula (QTcF) ≥450 msec ...

  10. A Study of Sporadic Angiomyolipomas Growth Kinetics While on Everolimus - Mayo Clinic

    ... mmol/L AND fasting triglycerides ≤ 2.5x ULN. Exclusion Criteria. History of tuberous sclerosis, LAM or any active malignancy; Treatment with any other ...